MedTrace Logo

Schizophrenic Patients Taking Part in Integrated Care Program

NCT00617214 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2010-12-10

No results posted yet for this study

Summary

Purpose of this non-interventional study (NIS) is to assess the effect of the participation in an integrated care program on treatment outcomes in patients treated with Seroquel for schizophrenia.

Conditions

  • Schizophrenia
  • Schizoaffective Disorder
  • Schizophreni-form Disorder
  • Delusional Disorder
  • Psychotic Disorder Not Otherwise Specified

Sponsors & Collaborators

  • acromion GmbH

    collaborator INDUSTRY

  • AstraZeneca

    lead INDUSTRY

Principal Investigators

  • Sandra Liedtke, MD · AstraZeneca

  • Martin Lambert, PD, MD · University of Hamberg

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2008-12-31
Completion
2008-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00617214 on ClinicalTrials.gov